Low LeverageA debt-free balance sheet provides durable financial flexibility and lower fixed obligations, helping the company survive operating losses and buy time for product development or commercialization without immediate interest burdens that can accelerate insolvency risk.
Proprietary Digital TherapeuticsA software-first, proprietary cognitive assessment/training product is scalable with favorable unit economics and potential for recurring engagement, data-driven improvements, and regulatory/clinical validation — structural advantages in digital health markets.
Moderating Cash BurnMaterial improvement in operating cash outflow signals stronger cost control and operational discipline. Slower cash burn extends runway and reduces frequency of external raises, improving prospects for executing commercialization or product iteration plans.